Academic Journal
Q1European Heart Journal: Acute Cardiovascular Care
About European Heart Journal: Acute Cardiovascular Care
About European Heart Journal: Acute Cardiovascular Care
European Heart Journal: Acute Cardiovascular Care is a peer-reviewed scholarly journal published by Oxford University Press (United Kingdom). It focuses on Q1. Publication coverage spans 2012-2026.
Key indicators: ISSN 2048-8734, 2048-8726; H-index 64.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (64): Strong citation impact — 64 articles cited at least 64 times each, reflecting solid influence.
Publishing in European Heart Journal: Acute Cardiovascular Care
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of European Heart Journal: Acute Cardiovascular Care?
2048-8734, 2048-8726.
Who publishes European Heart Journal: Acute Cardiovascular Care?
Oxford University Press.
What are European Heart Journal: Acute Cardiovascular Care's metrics?
H-index 64.
Where do I submit to European Heart Journal: Acute Cardiovascular Care?
Via the official website.
Is European Heart Journal: Acute Cardiovascular Care peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Acute Myocardial Infarction Research; Mechanical Circulatory Support Devices; Cardiac Arrest and Resuscitation; Cardiac Imaging and Diagnostics; Heart Failure Treatment and Management; Coronary Interventions and Diagnostics.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,355.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reply to: Did prolonged high-level pump support precede acute kidney injury?
Takahiro Nakashima, Takashi Unoki, Kenichi Tsujita
2026-10-07 · DOI: 10.1093/ehjacc/zuag122Prognostic implications of complications during VA-ECMO for cardiogenic shock
Aniket S Rali, Dhruv Sarma, Hui Li, Martin Urner et al.
2026-10-06 · DOI: 10.1093/ehjacc/zuag127Answer: Acute chest pain in Duchenne muscular dystrophy
Mónica Dias, Fernando Mané, Rui Files Flores
2026-10-05 · DOI: 10.1093/ehjacc/zuag065We didn’t start the fire
Pascal Vranckx, David Morrow, Sean van Diepen, Frederik H Verbrugge et al.
2026-10-05 · DOI: 10.1093/ehjacc/zuag123Inflammation, Infarct Size and 10-Year Mortality in STEMI Patients Stratified by the ORBI Risk Score: A DANAMI-3 Sub-study
Joakim Bo Kunkel, Jacob Lønborg, Martin Frydland, Burcu Tas Özbek et al.
2026-10-03 · DOI: 10.1093/ehjacc/zuag126At what RATE are we bleeding? Rethinking anticoagulation during mechanical circulatory support
Christophe Vandenbriele, Alessandro Galluzzo, Janine Pöss, Tharusan Thevathasan et al.
2026-09-30 · DOI: 10.1093/ehjacc/zuag125Question: Acute chest pain in Duchenne muscular dystrophy
Mónica Dias, Fernando Mané, Rui Files Flores
2026-09-28 · DOI: 10.1093/ehjacc/zuag064Did prolonged high-level pump support precede acute kidney injury?
Xiang Zhou, Zhengdong Hua
2026-09-15 · DOI: 10.1093/ehjacc/zuag121Supplemental oxygen in acute heart failure: is less more?
Alessandro Galluzzo, Tharusan Thevathasan
2026-09-08 · DOI: 10.1093/ehjacc/zuag117Electrocardiographic principles for the diagnosis of occlusion myocardial infarction
Hans C Helseth, Pedro Mansur, Mazen El-Baba, Jesse T T McLaren et al.
2026-09-03 · DOI: 10.1093/ehjacc/zuag114Influences of socioeconomic and environmental factors on STEMI incidence and related mortality: insights from the Belgian Environmental Myocardial Infarction Risk (EMIR) Study
Tom De Potter, Christel Faes, Andreea Motoc, Els Verachtert et al.
2026-09-02 · DOI: 10.1093/ehjacc/zuag118Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3–PRIMULTI trial
Yan Zhou, Burcu Tas Özbek, Jasmine Melissa Marquard, Utsho Islam et al.
2026-09-02 · DOI: 10.1093/ehjacc/zuag112PRAGUE-26 in perspective: convincing early stabilization, but durable benefit remains unproven
Johannes Grand, David A Morrow
2026-09-30 · DOI: 10.1093/ehjacc/zuag119Answer: A dangerous beat in the postpartum heart
Amin Esmailian, Lung En Teng, Ojas Mehta
2026-09-30 · DOI: 10.1093/ehjacc/zuag054Proximity where possible, concentration where needed
Pascal Vranckx, David Morrow, Sean van Diepen, Frederik H Verbrugge et al.
2026-09-30 · DOI: 10.1093/ehjacc/zuag105Truncating tradition in the POET II trial: is a shorter course of antibiotics non-inferior to standard length therapy in left-sided endocarditis?
Frederik H Verbrugge, Sean van Diepen
2026-09-30 · DOI: 10.1093/ehjacc/zuag120Prognostic impact of pericardial effusion in patients with acute myocarditis
Matthieu Proust, Florent Huang, Michel Zeitouni, Nadjib Hammoudi et al.
2026-08-31 · DOI: 10.1093/ehjacc/zuag090Question: A dangerous beat in the postpartum heart
Amin Esmailian, Lung En Teng, Ojas Mehta
2026-09-30 · DOI: 10.1093/ehjacc/zuag053Injectable antiplatelet therapies in acute coronary syndromes: current status and emerging therapies
Uwe Zeymer, Sogol Koolaji, Diego Araiza-Garaygordobil, Peter Clemmensen et al.
2026-08-21 · DOI: 10.1093/ehjacc/zuag113Frailty assessment and the risk of major adverse cardiovascular events after elective surgery
Bhavik Bansal, Ambarish Pandey, Milind Desai, Grant Reed et al.
2026-08-19 · DOI: 10.1093/ehjacc/zuag108Reviews
Community Reviews
Version History
October 9, 2026 at 7:12 pm
September 25, 2026